MRI contrast media agents play a crucial role in the health industry today as they enhance the diagnostic capabilities of magnetic resonance imaging (MRI) scans. These agents contain substances that improve the visibility and differentiation of specific tissues and structures within the body, aiding in the detection, characterization, and monitoring of various diseases and conditions.
DataM Intelligence’s MRI contrast media agents market report highlights the global increasing chronic diseases, and advances in technology as the major market drivers. Adverse reactions to MRI contrast media agents are hampering the global MRI contrast media agents market growth.
In recent years, the global MRI contrast media agents market has witnessed a series of product launches and approvals that have contributed to its growth. DataM Intelligence's in-depth market analysis reveals the major MRI contrast media agents market drivers, challenges, trends, and opportunities. Our market intelligence report evaluates the MRI contrast media agents market size, growth, and share, providing crucial insights for businesses to make informed decisions and capitalize on the existing and upcoming opportunities in the MRI contrast media agents market.
Increasing Chronic Diseases are Driving the Global MRI Contrast Media Agents Market Growth
The incidence of chronic diseases such as cancer, neurological disorders, cardiovascular problems, and musculoskeletal ailments has raised the necessity for diagnostic imaging modalities such as MRI. The use of MRI contrast media agents improves the accuracy and sensitivity of MRI scans, which aids in the diagnosis and treatment monitoring of many illnesses.
Despite advances in general health, the WHO cautioned that if noncommunicable disease trends persisted, chronic diseases such as cancer, diabetes, and respiratory ailments would account for 86% of the 90 million yearly deaths by 2050. In absolute terms, this marks a staggering 90% growth from 2019.
Technological Advancements are Propelling the Growth of the Global MRI Contrast Media Agents Market
Magnetic Resonance Imaging (MRI), a medical imaging technique, is already considered the most cutting-edge imaging alternative; nonetheless, MRI technology is always being enhanced. Magnetic resonance imaging (MRI) is one of the most effective imaging procedures in the radiology field. It is an imaging method that uses magnetic fields of varying gradients to produce anatomical and physiological pictures of the body. As a result, the MRI contrast media market revenue is increasing for applications in examining different organ dysfunctions.
For example, Functional MRI (fMRI) is used to monitor brain activity, whereas diffusion MRI is used to map the structure of white matter in the brain, and MR angiography is used to identify blood veins. These advancements improve patient care and expand the capabilities of MRI.
Adverse Reactions to MRI Contrast Media Agents are the Market Growth
Because adverse responses to MRI contrast media agents are highly uncommon, they are often thought to be harmless. Anaphylaxis and other allergic reactions may occur in certain persons. Several contrast agents may cause nephrogenic systemic fibrosis (NSF) in people with impaired kidney function. These safety concerns may make certain patient groups less inclined to use contrast media agents, but they may also urge cautious prescription behaviors.
Market Size and Growth Analysis:
According to the latest research report published by DataM Intelligence, the Global MRI Contrast Media Agents Market was valued at US$ 2.1 billion in 2022 and is projected to reach US$ 3.5 billion by 2030. The market is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030).
Market Opportunities:
Increasing competition among leading market competitors, as well as the generic lane of contrast media, have emerged as potential opportunities for market expansion. Furthermore, the attractive offers made by reimbursement facilities and insurance companies have contributed significantly to the contrast media market's revenue growth. Moreover, tremendous advancements in the healthcare sector in developing countries have increased the usage of improved contrast media for imaging procedures.
Competitive Landscape:
These businesses concentrate on product innovation, quality control, marketing tactics, and distribution network growth to keep a competitive advantage in the market. Players often use partnerships, collaborations, mergers, and acquisitions to improve their market positions.
The major companies in the global MRI contrast media agents market include
- GE Healthcare
- Bracco Imaging SPA
- Bayer AG
- Guerbet
- Lantheus Medical Imaging
- Unijules Life Sciences
- B. Chemicals and Pharmaceuticals Ltd.
- SANOCHEMIA Pharmazeutika GmbH
- Taejoon Pharm, and Jodas Expoim
GE Healthcare
At GE HealthCare, they see possibilities through innovation. They are partnering with their customers to fulfill healthcare’s greatest potential through groundbreaking medical technology, intelligent devices, and care solutions. Better tools enable better patient care. Together, they are not only building a healthier future but living their purpose to create a world where healthcare has no limits.
GE HealthCare has a distinguished history of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.
To Know More Download Sample
